Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Hypofractionated radiotherapy in rectal cancer for elderly patients].
Servagi Vernat S, Guilbert P, Bouché G, Ramiandrisoa F, Bellefqih S. Servagi Vernat S, et al. Cancer Radiother. 2018 Oct;22(6-7):644-646. doi: 10.1016/j.canrad.2018.07.130. Epub 2018 Aug 27. Cancer Radiother. 2018. PMID: 30166091 Review. French.
[Clinical to planning target volume margins in prostate cancer radiotherapy].
Ramiandrisoa F, Duvergé L, Castelli J, Nguyen TD, Servagi-Vernat S, de Crevoisier R. Ramiandrisoa F, et al. Among authors: servagi vernat s. Cancer Radiother. 2016 Oct;20(6-7):629-39. doi: 10.1016/j.canrad.2016.07.095. Epub 2016 Sep 7. Cancer Radiother. 2016. PMID: 27614515 Review. French.
Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
Vandendorpe B, Durot C, Lebellec L, Le Deley MC, Sylla D, Bimbai AM, Amroun K, Ramiandrisoa F, Cordoba A, Mirabel X, Hoeffel C, Pasquier D, Servagi-Vernat S. Vandendorpe B, et al. Among authors: servagi vernat s. Radiother Oncol. 2019 Jun;135:153-160. doi: 10.1016/j.radonc.2019.03.011. Epub 2019 Mar 27. Radiother Oncol. 2019. PMID: 31015162
[Radiotherapy of larynx cancers].
Pointreau Y, Lafond C, Legouté F, Trémolières P, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M. Pointreau Y, et al. Among authors: servagi vernat s. Cancer Radiother. 2016 Sep;20 Suppl:S131-5. doi: 10.1016/j.canrad.2016.07.018. Epub 2016 Aug 9. Cancer Radiother. 2016. PMID: 27521037 French.
[Radiotherapy of hypopharynx cancers].
Pointreau Y, Lafond C, Trémolières P, Legouté F, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M. Pointreau Y, et al. Among authors: servagi vernat s. Cancer Radiother. 2016 Sep;20 Suppl:S126-30. doi: 10.1016/j.canrad.2016.07.020. Epub 2016 Aug 10. Cancer Radiother. 2016. PMID: 27522185 French.
Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis.
Issoufaly I, Petit C, Guihard S, Eugène R, Jung L, Clavier JB, Servagi Vernat S, Bellefqih S, Verret B, Bonnet N, Deutsch É, Rivera S. Issoufaly I, et al. Among authors: servagi vernat s. Radiat Oncol. 2022 Apr 20;17(1):80. doi: 10.1186/s13014-022-02044-z. Radiat Oncol. 2022. PMID: 35443729 Free PMC article.
[Radiotherapy of oropharynx carcinoma].
Servagi Vernat S, Tochet F, Vieillevigne L, Pointreau Y, Maingon P, Giraud P. Servagi Vernat S, et al. Cancer Radiother. 2016 Sep;20 Suppl:S110-5. doi: 10.1016/j.canrad.2016.07.017. Epub 2016 Aug 9. Cancer Radiother. 2016. PMID: 27521033 French.
71 results